I-Mab
Patents, Design & Utilities
Last updated:
List of all I-Mab patents 35 in total
Status | Patent |
---|---|
Grant | Utility: Anti-PD-L1 antibody and IL-7 fusions Filling date: 5 Sep 2025 Issue date: 2 Aug 2022 |
Application | Utility: ANTI-PD-L1 ANTIBODIES AND USES THEREOF Filling date: 5 Sep 2025 Issue date: 21 Apr 2022 |
Application | Utility: BIFUNCTIONAL MOLECULES WITH IL-7 ACTIVITY Filling date: 5 Sep 2025 Issue date: 14 Apr 2022 |
Grant | Utility: Anti-claudin 18.2 and anti-4-1BB bispecific antibodies and uses thereof Filling date: 5 Sep 2025 Issue date: 1 Mar 2022 |
Application | Utility: ANTI-PD-L1/ANTI-4-1BB BISPECIFIC ANTIBODIES AND USES THEREOF Filling date: 5 Sep 2025 Issue date: 24 Feb 2022 |
Grant | Utility: Anti-PD-L1 antibodies and uses thereof Filling date: 5 Sep 2025 Issue date: 11 Jan 2022 |
Grant | Utility: Human PD-L1 antibodies Filling date: 5 Sep 2025 Issue date: 28 Dec 2021 |
Application | Utility: ANTI-IFNAR1 ANTIBODIES FOR TREATING AUTOIMMUNE DISEASES Filling date: 5 Sep 2025 Issue date: 11 Nov 2021 |
Application | Utility: ANTI-CLAUDIN 18.2 AND ANTI-4-IBB BISPECIFIC ANTIBODIES AND USES THEREOF Filling date: 5 Sep 2025 Issue date: 14 Oct 2021 |
Application | Utility: ANTI-CXCL13 ANTIBODIES FOR TREATING AUTOIMMUNE DISEASES AND CANCER Filling date: 5 Sep 2025 Issue date: 16 Sep 2021 |
Application | Utility: Novel CD47 Antibodies and Methods of Using Same Filling date: 5 Sep 2025 Issue date: 2 Sep 2021 |
Grant | Utility: Anti-IFNAR1 antibodies for treating autoimmune diseases Filling date: 5 Sep 2025 Issue date: 13 Jul 2021 |
Grant | Utility: Anti-CD73 anti-PD-L1 bispecific antibodies Filling date: 5 Sep 2025 Issue date: 15 Jun 2021 |
Grant | Utility: Anti-CXCL13 antibodies Filling date: 5 Sep 2025 Issue date: 8 Jun 2021 |
Grant | Utility: Antibodies to T cell immunoreceptor with IG and ITIM domains (TIGIT) and uses thereof Filling date: 5 Sep 2025 Issue date: 13 Apr 2021 |
Application | Utility: Fusion Proteins Containing CD47 Antibodies and Cytokines Filling date: 5 Sep 2025 Issue date: 1 Apr 2021 |
Application | Utility: ANTI-GM-CSF ANTIBODIES AND USES THEREOF Filling date: 5 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: Novel CD47 Monoclonal Antibodies and Uses Thereof Filling date: 5 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: ANTIBODIES TO T CELL IMMUNORECEPTOR WITH IG AND ITIM DOMAINS (TIGIT) AND USES THEREOF Filling date: 5 Sep 2025 Issue date: 21 Jan 2021 |
Grant | Utility: Anti-GM-CSF antibodies and uses thereof Filling date: 5 Sep 2025 Issue date: 12 Jan 2021 |
Application | Utility: Fusion Proteins Containing CD48 Antibodies and Cytokines Filling date: 5 Sep 2025 Issue date: 31 Dec 2020 |
Application | Utility: ANTI-IFNAR1 ANTIBODIES FOR TREATING AUTOIMMUNE DISEASES Filling date: 5 Sep 2025 Issue date: 24 Dec 2020 |
Application | Utility: ANTI-CXCL13 ANTIBODIES FOR TREATING AUTOIMMUNE DISEASES AND CANCER Filling date: 5 Sep 2025 Issue date: 24 Dec 2020 |
Application | Utility: Novel CD47 Monoclonal Antibodies and Uses Thereof Filling date: 5 Sep 2025 Issue date: 3 Dec 2020 |
Application | Utility: ANTI-CD73 ANTI-PD-L1 BISPECIFIC ANTIBODIES Filling date: 5 Sep 2025 Issue date: 5 Nov 2020 |
Application | Utility: ANTI-CD73 ANTIBODIES AND USES THEREOF Filling date: 5 Sep 2025 Issue date: 22 Oct 2020 |
Application | Utility: ANTI-PD-L1 ANTIBODIES AND USES THEREOF Filling date: 5 Sep 2025 Issue date: 8 Oct 2020 |
Grant | Utility: Anti-PD-L1 antibodies and uses thereof Filling date: 5 Sep 2025 Issue date: 28 Jul 2020 |
Application | Utility: NOVEL CD47 MONOCLONAL ANTIBODIES AND USES THEREOF Filling date: 5 Sep 2025 Issue date: 7 May 2020 |
Grant | Utility: Anti-CD73 antibodies and uses thereof Filling date: 5 Sep 2025 Issue date: 10 Mar 2020 |
Application | Utility: ANTI-LAG-3 ANTIBODIES AND USES THEREOF Filling date: 5 Sep 2025 Issue date: 5 Mar 2020 |
Grant | Utility: Anti-LAG-3 antibodies and uses thereof Filling date: 5 Sep 2025 Issue date: 3 Mar 2020 |
Application | Utility: MODIFIED CK AND CH1 DOMAINS Filling date: 5 Sep 2025 Issue date: 26 Dec 2019 |
Application | Utility: ANTI-PD-L1 ANTIBODY AND IL-7 FUSIONS Filling date: 5 Sep 2025 Issue date: 21 Nov 2019 |
Application | Utility: ANTI-CD73 ANTIBODIES AND USES THEREOF Filling date: 5 Sep 2025 Issue date: 22 Aug 2019 |
Showing 1 to 35 of 35 patents.